Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 53

1.

Risk for subsequent venous thromboembolic complications in carriers of the prothrombin or the factor V gene mutation with a first episode of deep-vein thrombosis.

Simioni P, Prandoni P, Lensing AW, Manfrin D, Tormene D, Gavasso S, Girolami B, Sardella C, Prins M, Girolami A.

Blood. 2000 Nov 15;96(10):3329-33.

3.

Factor V Leiden mutation and the risks for thromboembolic disease: a clinical perspective.

Price DT, Ridker PM.

Ann Intern Med. 1997 Nov 15;127(10):895-903. Review.

PMID:
9382368
4.

Risk of recurrent venous thromboembolism in patients with common thrombophilia: a systematic review.

Ho WK, Hankey GJ, Quinlan DJ, Eikelboom JW.

Arch Intern Med. 2006 Apr 10;166(7):729-36. Review.

PMID:
16606808
5.

[G20210A transition in the prothrombin gene and venous thromboembolic disease].

Trillot N, Zawadzki C, Watel A, Jude B.

Rev Med Interne. 2000 Oct;21(10):911-4. Review. French.

PMID:
11075405
6.
8.

[Thromboembolism--genetic and acquired risk factors].

Pabinger-Fasching I.

Acta Med Austriaca. 1999;26(2):37-40. Review. German.

PMID:
10478276
9.

Duration of anticoagulant treatment for venous thrombosis.

Raskob GE.

Curr Opin Pulm Med. 1997 Jul;3(4):286-90. Review.

PMID:
9262115
10.

Recurrence of venous thromboembolism in patients with familial thrombophilia.

van den Belt AG, Sanson BJ, Simioni P, Prandoni P, Büller HR, Girolami A, Prins MH.

Arch Intern Med. 1997 Oct 27;157(19):2227-32. Review.

PMID:
9342999
11.

The prothrombin gene variant 20210A in venous and arterial thromboembolism.

Vicente V, González-Conejero R, Rivera J, Corral J.

Haematologica. 1999 Apr;84(4):356-62. Review.

12.

[A new mutation in the prothrombin gene (G20210A) and the risk for venous and arterial thromboembolism].

Misgav M, Eldor A, Berliner S.

Harefuah. 2000 Jul;139(1-2):51-6. Review. Hebrew. No abstract available.

PMID:
10979454
13.

Novel inherited risk factors for venous thrombosis.

Key NS.

J Lab Clin Med. 1998 Dec;132(6):444-5. Review. No abstract available.

PMID:
9851730
14.

Review and management of patients with the prothrombin G20210A polymorphism.

Nguyen A.

Clin Appl Thromb Hemost. 2000 Apr;6(2):94-9. Review.

PMID:
10775030
15.

Factor V Leiden as a common genetic risk factor for venous thromboembolism.

Horne MK 3rd, McCloskey DJ.

J Nurs Scholarsh. 2006;38(1):19-25. Review.

PMID:
16579319
16.

Inherited risk factors for venous thromboembolism: implications for clinical practice.

Ridker PM.

Clin Cornerstone. 2002;4(6):18-30. Review.

PMID:
12739328
17.

[New causes of inherited thrombophilia].

Quéré I, Emmerich J.

Rev Med Interne. 1997;18 Suppl 6:626s-635s. Review. French.

PMID:
9515143
18.

Differential risks in men and women for first and recurrent venous thrombosis: the role of genes and environment.

Roach RE, Cannegieter SC, Lijfering WM.

J Thromb Haemost. 2014 Oct;12(10):1593-600. doi: 10.1111/jth.12678. Epub 2014 Aug 26. Review.

PMID:
25081183
19.

Thromboembolism risk following recurrent miscarriage.

Martínez-Zamora MÁ, Cervera R, Balasch J.

Expert Rev Cardiovasc Ther. 2013 Nov;11(11):1503-13. doi: 10.1586/14779072.2013.839201. Epub 2013 Oct 17. Review.

PMID:
24134441
20.

Clinical and laboratory management of the prothrombin G20210A mutation.

McGlennen RC, Key NS.

Arch Pathol Lab Med. 2002 Nov;126(11):1319-25. Review.

PMID:
12421139
Items per page

Supplemental Content

Write to the Help Desk